(Nuuvera.com)

Weed firms again urged to disclose U.S. risks

Toronto | Reuters — Canadian regulators on Thursday reiterated their call for listed cannabis producers with U.S. businesses to clearly disclose risks of operating there, and warned of potential punishment if U.S. federal anti-marijuana laws are more strictly enforced. The Canadian Securities Administrators (CSA) staff notice said stricter U.S. enforcement could result in “material consequences […] Read more



(CopperstateFarms.com)

Ontario pot firm Aphria selling U.S. stake

Reuters — Ontario marijuana company Aphria said on Friday it agreed to sell its minority stake in U.S.-based Copperstate Farms to Liberty Health Sciences for $20 million. Boards of Aphria and Liberty have unanimously approved the deal, which is expected to close in the second quarter. Aphria has been looking to hive off its business […] Read more


A hemp plant in Alberta. (Jennifer Blair photo)

Cannabis firm Aphria mulls sale of U.S. unit

Reuters — Canadian cannabis company Aphria said Thursday it was exploring “strategic alternatives,” including a sale, for its U.S. business, amid tightening enforcement of federal cannabis laws in the country. Earlier this year, the U.S. Department of Justice revoked an Obama administration policy that discouraged federal prosecutors from pursuing marijuana-related crimes in states that had […] Read more

(Nuuvera.com)

Ontario medical marijuana producers plan major merger

A southwestern Ontario greenhouse firm billed as one of Canada’s lowest-cost medical marijuana producers plans to expand its reach by buying a rival firm sourcing cannabis worldwide for processing. Aphria Inc., based at Leamington, Ont., announced Monday it has locked in a cash-and-stock deal to buy Toronto-based Nuuvera Inc. for $826 million. The deal, expcted […] Read more



(CanniMedTherapeutics.com)

Aurora, CanniMed to form Canadian weed giant

Two major players in the Canadian medical marijuana market are set to create one of the world’s biggest pot production firms in a friendly $1.1 billion cash-and-stock deal. Edmonton-based Aurora Cannabis announced an agreement Wednesday in which it will ante up on its previous hostile bid for CanniMed Therapeutics and buy all the shares of […] Read more



(Newstrike.ca)

CanniMed asks regulators to step in on hostile bid

Reuters — Medical marijuana company CanniMed Therapeutics has asked federal regulators to intervene as it seeks to prevent a hostile takeover by bigger rival Aurora Cannabis Inc. Saskatoon-based CanniMed said Monday it asked the Financial and Consumer Affairs Authority of Saskatchewan and the Ontario Securities Commission to declare that Aurora’s move to take its buyout […] Read more